FDA Inspection 1157825 — New York Blood Center Inc
The FDA completed an inspection of New York Blood Center Inc on October 15, 2021 in Freehold, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 15, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Freehold, NJ (United States)